Diagnostic Tree Internal Medicine Peer Reviewed

Ptyalism &
Julie Allen, BVMS, MS, DACVIM (Small Animal)
Antech Diagnostics

Pseudoptyalism
Drooling*

Ptyalism (excessive saliva** production) Pseudoptyalism (inability to swallow normal saliva

production; drooling**)

History & examination

• Complete physical examination, evaluating salivary gland size and symmetry
• Full neurologic examination
• Breed: Giant breeds (eg, St. Bernard) or Yorkshire and Maltese terriers (increased PSS incidence)
• A ge: Young animals likely to ingest toxins/FBs or have congenital issues; neoplasia likely in older animals
• History of vaccination (eg, rabies, calicivirus) or trauma (eg, electric cord injury)
• Exposure to toxins, medications, topical products
• Duration: Acute (eg, FB) vs chronic (eg, neoplasm)
• Discoloration of saliva (eg, blood, purulent discharge) suggestive of oral problem
• Halitosis may indicate oral, esophageal, or gastric disease
• Pawing at face/mouth may indicate orofacial pain, hypocalcemia
• Change in eating behavior: Dropping food, chewing on one side of the mouth, pseudoanorexia or hyporexia
• Diet (eg, high-protein) can cause drooling because of precipitation of HE in patients with liver dysfunction
• Other GI (ie, retching, regurgitation, vomiting, weight loss) or neurologic signs (ie, seizures, gagging, dysphagia)

Known toxin Known medication exposure

Toxicity Medication reaction

• Household cleaners • Medications/topical products given topically or PO
• Plants/trees (eg, Kentucky coffee tree, poinsettia) (eg, selamectin, moxidectin–imidacloprid)
• Insecticide/pesticide (eg, boric acid, aldicarb) • Cholinergic drugs (eg, bethanechol), anticholinesterase
• Rodenticide (eg, zinc phosphide) drugs (eg, pyridostigmine), cholinesterase inhibitors
• Illicit drugs (eg, cocaine, amphetamines) (eg, OP)
• Animal venoms (eg, black widow spider, scorpion, • Pyrethrins/pyrethroids
toads [Bufo spp], coral snake, sea hare [Aplysia spp]) • Ivermectin
• Human sleep aids (eg, zolpidem) • Bitter drugs
• Mushrooms (eg, Amanita muscaria)
• Metaldehyde
• Human tricyclic antidepressants (eg, clozapine)
• 5-hydroxytryptophan (ie, Griffonia seed extract)
• Discontinue medication
• Supportive care

• Depends on toxin exposure

• Dilution if caustic agent * Rabies should always be considered in patients presenting with
• Decontamination (eg, activated charcoal) drooling.
• Supportive care
• Specific antidote (if available) ** Distinction between ptyalism and pseudoptyalism is not absolute;
oropharyngeal and CNS diseases can result in increased salivary
production and inability to swallow.
† 
HE management includes low-protein diet, enemas, oral antibiotics,
lactulose, zinc supplementation, supportive care.
AChR Ab = acetylcholine receptor antibody, FB = foreign body, FNA =
fine-needle aspiration, HE = hepatic encephalopathy, OP = organophos-
phates, PSS = portosystemic shunt, SCC = squamous cell carcinoma,
T4 = thyroxine

12 cliniciansbrief.com • June 2014

 • Periodontal disease
• Stomatitis (eg, calicivirus, FeLV/FIV, caustic
agent) • Depends on underlying disease
• Immune-mediated disease (eg, pemphigus) • Dental cleaning/extractions
Oral cavity abnormal • Tongue lesion (eg, linear FB), glossitis • Antiinflammatory/
(eg, uremia, caustic agent), tumor immunomodulatory therapy
• Oropharyngeal disease (eg, tonsillar SCC) • Surgical resection/correction
• Lip fold abnormalities
• Faucitis

Oral cavity normal

Neurologic, GI signs, or abnormal salivary glands? No other findings?

Physiologic
Minimum database (CBC, chemistry panel, • Response to feeding
T4, UA) • Hyperthermia
• Excitement
• Purring

Additional diagnostics based on findings No other findings

• Bile acids (if HE suspected)
• FeLV/FIV testing
• AChR Ab test (if myasthenia gravis possible)
• FNA/biopsy of lesions (mucocutaneous, oropharyngeal, lingual) Idiopathic or nonresponsive
• FNA/biopsy of salivary glands
• Radiography (oral cavity, neck, thorax, abdomen)
• Abdominal ultrasonography
• Portal scintigraphy
• Fluoroscopic evaluation of swallowing • Atropine or glycopyrrolate to decrease salivary flow
• Preventive measures for moist dermatitis
• Fluid support (if dehydrated)
• Salivary gland removal

GI disease Neurologic disease Abnormal salivary glands

• Any disease resulting • Seizures • Sialadenitis, necrotizing sialo-

in nausea • Infectious disease (eg, metaplasia (ie, inflammation of
• Esophageal disease rabies, pseudorabies, salivary glands)
• Gastric dilatation– tetanus, botulism) • Sialadenosis–idiopathic non-
volvulus • Myasthenia gravis inflammatory salivary gland
• Gastric ulceration • Idiopathic trigeminal enlargement (may be form
• Renal failure neuritis of limbic epilepsy)
• Hepatic failure (HE; • Lesions of cranial nerves • Salivary gland neoplasia
particularly in cats) IX, X, XII • Salivary mucocele

• Treat underlying disease • Anticonvulsants • Sialadenitis: If immune Diagnosis

• Antiemetics, antacids • Other therapies, mediated, treat with Differential
for nausea depending on diagnosis immunosuppressive dose of Diagnosis
• HE management† corticosteroids ± phenobarbital
• Sialadenosis: Phenobarbital, Investigation
sclerotherapy
Treatment
•M  ucocele/neoplasia: Surgical
management Results

June 2014 • Clinician’s Brief 13